Finance & Capital Management

Moncton institute to get $5 million

Government should review support available to those caring for loved ones to ensure they can continue to do so for as long as they can

The Common Drug Review, the national body that provides the cost-benefit analysis of new pharmaceutical products for most provincial formularies, is enacting changes designed to get drugs onto formulary lists sooner.

Dr. Barbara Lent is pleased with the improved benefits and greater acceptance of maternity and parental leave for physicians across the nation in the last decade, but says many issues still must be considered when planning time off.

Overlapping deals mean association faces spending $6.1 million renting empty space